Search Results

Return to List
Results 1–20 of 37
Title Date
1.

Pain Relief During Labor

Number 295

(Reaffirmed 2008, Replaces No. 231, February 2000)

ABSTRACT Pain management should be provided whenever medically indicated The American Society of Anesthesiologists ASA and the American College of Obstetricians and Gynecologists ACOG believe that women requesting epidural analgesia during labor should not be deprived of this service based on thei...

July 2004

PDF Format
2.

Analgesia and Cesarean Delivery Rates

Number 339

(Reaffirmed 2013, Replaces No. 269, February 2002)

ABSTRACT Neuraxial analgesia techniques are the most effective and least depressant treatments for labor pain The American College of Obstetricians and Gynecologists previously recommended that practitioners delay initiating epidural analgesia in nulliparous women until the cervical dilatation rea...

June 2006

PDF Format
3.

Brand Versus Generic Oral Contraceptives

Number 375

(Reaffirmed 2013)

ABSTRACT The US Food and Drug Administration considers generic and brand name oral contraceptive OC products clinically equivalent and interchangeable The American College of Obstetricians and Gynecologists supports patient or clinician requests for branded OCs or continuation of the same generic ...

August 2007

PDF Format
4.

Nalbuphine Hydrochloride Use for Intrapartum Analgesia

Number 376

(Reaffirmed 2014)

ABSTRACT Safety concerns have been raised regarding the use of nalbuphine hydrochloride during labor The American College of Obstetricians and Gynecologists finds data are insufficient to recommend any changes in nalbuphine hydrochloride administration at this time Opinion Nalbuphine hydrochloride...

August 2007

PDF Format
5.

Aromatase Inhibitors in Gynecologic Practice

Number 412

(Reaffirmed 2014)

ABSTRACT Aromatase inhibitors appear to be effective as an adjuvant treatment for earlystage and latestage breast cancer Their role in chemoprevention of breast cancer in highrisk patients remains to be defined Side effects of aromatase inhibitors in postmenopausal women are due to estrogenlowerin...

August 2008

PDF Format
6.

Misoprostol for Postabortion Care

Number 427

ABSTRACT The World Health Organization estimates that 67000 women mostly in developing countries die each year from untreated or inadequately treated abortion complications Postabortion care a term commonly used by the international reproductive health community refers to a specific set of service...

February 2009

PDF Format
7.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Number 455

Reaffirmed 2015

Abstract Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format
8.

Nonobstetric Surgery During Pregnancy

Number 474

(Replaces No. 284, August 2003, Reaffirmed 2015)

ABSTRACT The American College of Obstetricians and Gynecologists Committee on Obstetric Practice acknowledges that the issue of nonobstetric surgery during pregnancy is an important concern for physicians who care for women It is important for a physician to obtain an obstetric consultation before...

February 2011

PDF Format
9.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Replaces No. 279, December 2002, Reaffirmed 2015)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
10.

Pharmacogenetics

Number 488

(Reaffirmed 2015)

ABSTRACT Pharmacogenetics is the study of genetic variations in drug response that are determined by specific genes It is hoped that the use of pharmacogenetics in clinical practice may improve drug safety and decrease the rate of adverse drug reactions Given the potential applications of pharmaco...

May 2011

PDF Format
11.

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Number 494

Reaffirmed 2013

Abstract The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed As with all patients antibiotics should be prescribed for pregnant women only for appropriate indications and for the shortest effective duration During the secon...

June 2011

PDF Format
12.

Vitamin D: Screening and Supplementation During Pregnancy

Number 495

ABSTRACT During pregnancy severe maternal vitamin D deficiency has been associated with biochemical evidence of disordered skeletal homeostasis congenital rickets and fractures in the newborn At this time there is insufficient evidence to support a recommendation for screening all pregnant women f...

July 2011

PDF Format
13.

Improving Medication Safety

Number 531

(Reaffirmed 2014, Replaces No. 331, April 2006 and No. 400, March 2008)

ABSTRACT Despite significant national attention medical errors continue to pervade the US health care system Medicationrelated errors consistently rank at the top of all medical errors which account for thousands of preventable deaths annually in the United States There are a variety of methodsran...

August 2012

PDF Format
14.

Compounded Bioidentical Menopausal Hormone Therapy

Number 532

(Reaffirmed 2014, Replaces No. 387, November 2007 and No. 322, November 2005)

ABSTRACT Although improvement in longterm health is no longer an indication for menopausal hormone therapy evidence supporting fewer adverse events in younger women combined with its high overall effectiveness has reinforced its usefulness for shortterm treatment of menopausal symptoms Menopausal ...

August 2012

PDF Format
15.

Nonmedical Use of Prescription Drugs

Number 538

Reaffirmed 2014

ABSTRACT The nonmedical use of prescription drugs particularly opioids sedatives and stimulants has been cited as epidemic in the United States accounting for increasing numbers of emergency department visits and deaths from reactions and overdoses The prevalence of prescription drug abuse is simi...

October 2012

PDF Format
16.

Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills

Number 540

(Reaffirmed 2014)

ABSTRACT Although the risk of venous thromboembolism is increased among oral contraceptive users compared with nonusers who are not pregnant and not taking hormones and some data have suggested that use of drospirenonecontaining pills has a higher risk of venous thromboembolism this risk is still ...

November 2012

PDF Format
17.

Professional Relationships With Industry

Number 541

(Replaces No. 401, March 2008)

ABSTRACT The American College of Obstetricians and Gynecologists the College has a long history of leadership in ensuring that its educational mission is evidence based and unbiased A predecessor to this Committee Opinion was published in 1985 making the College one of the first professional assoc...

November 2012

PDF Format
18.

Access to Emergency Contraception

Number 542

ABSTRACT Emergency contraception includes contraceptive methods used to prevent pregnancy in the first few days after unprotected intercourse sexual assault or contraceptive failure Although the US Food and Drug Administration approved the first dedicated product for emergency contraception in 199...

November 2012

PDF Format
19.

Over-the-Counter Access to Oral Contraceptives

Number 544

(Reaffirmed 2014)

ABSTRACT Unintended pregnancy remains a major public health problem in the United States Access and cost issues are common reasons why women either do not use contraception or have gaps in use A potential way to improve contraceptive access and use and possibly decrease unintended pregnancy rates ...

December 2012

PDF Format
20.

Postmenopausal Estrogen Therapy: Route of Administration and Risk of Venous Thromboembolism

Number 556

(Reaffirmed 2015)

ABSTRACT The development of menopausal symptoms and related disorders which lead women to seek prescriptions for postmenopausal estrogen therapy and hormone therapy is a common reason for a patient to visit her gynecologist but these therapies are associated with an increased risk of venous thromb...

April 2013

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998